Profile picture

Doctor Samuel Z Goldhaber

Brigham and Women's Hospital, Boston (United States of America)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Preventing PE & DVT in heart failure and other medically ill patients: an innovative action plan
Session
Preventing PE & DVT in heart failure and other medically ill patients: an innovative action plan
28 August 2018
Preventing PE & DVT in heart failure and other medically ill patients: an innovative action plan
Session
Preventing PE & DVT in heart failure and other medically ill patients: an innovative action plan
27 August 2018
New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients
Session
New DOACs to prevent pulmonary embolism and stroke in heart failure and other hospitalized patients
29 August 2017
Practical dimensions of novel anticoagulant-based prevention of stroke in atrial fibrillation and management of acute venous thromboembolism
Session
Practical dimensions of novel anticoagulant-based prevention of stroke in atrial fibrillation and management of acute venous thromboembolism
29 August 2016
Practical dimensions of NOAC-based management of stroke prevention in Atrial Fibrillation (AF) and acute coronary syndrome
Session
Practical dimensions of NOAC-based management of stroke prevention in Atrial Fibrillation (AF) and acute coronary syndrome
30 August 2015
World-wide clinical use of NOACs: how are we using them?
Session
World-wide clinical use of NOACs: how are we using them?
30 August 2015
New advances and practical dimensions of optimizing management of acute coronary syndrome: evidence-based use of oral factor Xa inhibition to improve outcomes in patients with acute coronary syndrome (ACS) - Risk stratification, patient selection, and clinical pearls for oral factor Xa-based management
Session
New advances and practical dimensions of optimizing management of acute coronary syndrome: evidence-based use of oral factor Xa inhibition to improve outcomes in patients with acute coronary syndrome (ACS) - Risk stratification, patient selection, and clinical pearls for oral factor Xa-based management
31 August 2014
New frontiers and treatment paradigms for stroke prevention in atrial fibrillation: translating landmark trials, ESC Guidelines, and expert-based analysis to the front lines of cardiovascular care for patients with nonvalvular atrial fibrillation
Session
New frontiers and treatment paradigms for stroke prevention in atrial fibrillation: translating landmark trials, ESC Guidelines, and expert-based analysis to the front lines of cardiovascular care for patients with nonvalvular atrial fibrillation
1 September 2013

ESC 365 is supported by